SG11201804598RA - Flavoured nicotine powder - Google Patents
Flavoured nicotine powderInfo
- Publication number
- SG11201804598RA SG11201804598RA SG11201804598RA SG11201804598RA SG11201804598RA SG 11201804598R A SG11201804598R A SG 11201804598RA SG 11201804598R A SG11201804598R A SG 11201804598RA SG 11201804598R A SG11201804598R A SG 11201804598RA SG 11201804598R A SG11201804598R A SG 11201804598RA
- Authority
- SG
- Singapore
- Prior art keywords
- nicotine
- international
- powder
- pct
- particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0011—Details of inhalators; Constructional features thereof with microcapsules, e.g. several in one dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0063—Storages for pre-packed dosages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Seasonings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -' Organization International Bureau (43) International Publication Date ..... .....r ...) 29 June 2017(29.06.2017) WIPO I PCT (10) WO International 111111111111311111111111111111111111111111111111111111111111111111111311111111111111111 2017/109625 Publication Al Number (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 9/00 (2006.01) A61K 9/14 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A61K 47/18 (2017.01) A61K 31/465 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (21) International Application Number: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, PCT/IB2016/057452 NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (22) International Filing Date: RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, 8 December 2016 (08.12.2016) TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 15202728.0 24 December 2015 (24.12.2015) EP TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: PHILIP MORRIS PRODUCTS S.A. DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, [CH/CH]; Quai Jeanrenaud 3, 2000 Neuchatel (CH). LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, (72) Inventor: ZUBER, Gerard; Route du Chalet a Gobet 2, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, 1055 Froideville (CH). GW, KM, ML, MR, NE, SN, TD, TG). (81) Designated States (unless otherwise indicated, for every Published: kind of national protection available): AE, AG, AL, AM, — with international search report (Art 21(3)) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (54) Title: FLAVOURED NICOTINE POWDER ( 10 12 20 14 I 1 1-1 .4t 13 in ei V: c, C --... (57) : A nicotine powder inhaler tion (14), an airflow channel (15) extending I-1 c:::, ceptacle (20) disposed along the airflow channel, and a powder system disposed within the nicotine powder receptacle. The powder N system includes a first plurality of particles having a particle 0 second plurality of particles having a particle size of about particles comprise an amino acid or nicotine selected from the group consisting of nicotine pyruvate, nicotine mono-pyruvate, nicot - ine aspartate and nicotine lactate. 11A (10) comprises a body between the mouthpiece 20 FIG. size 11B 15 1 extending between a mouthpiece portion (12) and a distal end por- portion and the distal end portion and a nicotine powder re - of about (10) micrometres or less and including nicotine and a micrometres of greater and including flavour. The first plurality of
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15202728 | 2015-12-24 | ||
PCT/IB2016/057452 WO2017109625A1 (en) | 2015-12-24 | 2016-12-08 | Flavoured nicotine powder |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201804598RA true SG11201804598RA (en) | 2018-07-30 |
Family
ID=55066404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201804598RA SG11201804598RA (en) | 2015-12-24 | 2016-12-08 | Flavoured nicotine powder |
Country Status (20)
Country | Link |
---|---|
US (2) | US10751336B2 (en) |
EP (1) | EP3393451B1 (en) |
JP (2) | JP2019505479A (en) |
KR (1) | KR20180098247A (en) |
CN (2) | CN117695207A (en) |
AU (1) | AU2016376027B2 (en) |
BR (1) | BR112018010685A8 (en) |
CA (1) | CA3008208A1 (en) |
ES (1) | ES2952674T3 (en) |
HU (1) | HUE063028T2 (en) |
IL (1) | IL259936B2 (en) |
MX (1) | MX2018007507A (en) |
MY (1) | MY186270A (en) |
PH (1) | PH12018501142A1 (en) |
PL (1) | PL3393451T3 (en) |
RU (1) | RU2762084C2 (en) |
SG (1) | SG11201804598RA (en) |
UA (1) | UA122699C2 (en) |
WO (1) | WO2017109625A1 (en) |
ZA (1) | ZA201803584B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200023285A (en) * | 2017-06-28 | 2020-03-04 | 필립모리스 프로덕츠 에스.에이. | Container with particles for use with inhaler |
MX2022005510A (en) * | 2019-11-14 | 2022-06-08 | Philip Morris Products Sa | Improved tobacco flavoured dry powder formulation. |
WO2023138670A1 (en) * | 2022-01-21 | 2023-07-27 | The University Of Hong Kong | Dual targeting powder formulation of antiviral agent for nasal and lung deposition through single intranasal administration |
WO2024090890A1 (en) * | 2022-10-27 | 2024-05-02 | 주식회사 케이티앤지 | Low-dose nicotine dry powder inhalation composition |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735217A (en) | 1986-08-21 | 1988-04-05 | The Procter & Gamble Company | Dosing device to provide vaporized medicament to the lungs as a fine aerosol |
NO168921C (en) | 1989-07-31 | 1992-04-22 | Svein Knudsen | SMOKE-FREE Cigarette replacement for use in smoking cessation OR FOR USE IN SMOKE-FREE ENVIRONMENTS |
US5441060A (en) | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
CN1210017C (en) | 2000-10-12 | 2005-07-13 | 贝林格尔英格海姆法玛两合公司 | Novel tiotropiumonium-containing inhalation powder |
GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
GB2461008B (en) | 2006-12-08 | 2011-08-10 | Exchange Supplies Ltd | Nicotine inhalation device |
CA2963423C (en) | 2007-03-30 | 2020-07-28 | Philip Morris Products S.A. | Device and method for delivery of a medicament |
GB0712308D0 (en) * | 2007-06-25 | 2007-08-01 | Kind Group Ltd | An inhalable composition |
EP2399637B1 (en) * | 2009-02-23 | 2014-10-22 | Japan Tobacco, Inc. | Non-heating tobacco flavor suction device |
WO2012078804A1 (en) | 2010-12-07 | 2012-06-14 | Respira Therapeutics, Inc. | Dry powder inhaler |
US20140088044A1 (en) | 2012-09-21 | 2014-03-27 | Basil Rigas | Product comprising a nicotine-containing material and an anti-cancer agent |
US20140261488A1 (en) * | 2013-03-15 | 2014-09-18 | Altria Client Services Inc. | Electronic smoking article |
CN105828819A (en) * | 2014-04-08 | 2016-08-03 | 桑萨(巴巴多斯)公司 | Nicotine formulations and methods of making the same |
CA2943746C (en) * | 2014-04-28 | 2023-08-15 | Philip Morris Products S.A. | Flavoured nicotine powder inhaler |
-
2016
- 2016-12-08 MY MYPI2018702108A patent/MY186270A/en unknown
- 2016-12-08 US US16/064,170 patent/US10751336B2/en active Active
- 2016-12-08 PL PL16812864.3T patent/PL3393451T3/en unknown
- 2016-12-08 JP JP2018529277A patent/JP2019505479A/en active Pending
- 2016-12-08 KR KR1020187016365A patent/KR20180098247A/en not_active Application Discontinuation
- 2016-12-08 HU HUE16812864A patent/HUE063028T2/en unknown
- 2016-12-08 EP EP16812864.3A patent/EP3393451B1/en active Active
- 2016-12-08 WO PCT/IB2016/057452 patent/WO2017109625A1/en active Application Filing
- 2016-12-08 CN CN202311657737.6A patent/CN117695207A/en active Pending
- 2016-12-08 CN CN201680070878.XA patent/CN108289841A/en active Pending
- 2016-12-08 MX MX2018007507A patent/MX2018007507A/en unknown
- 2016-12-08 CA CA3008208A patent/CA3008208A1/en active Pending
- 2016-12-08 SG SG11201804598RA patent/SG11201804598RA/en unknown
- 2016-12-08 ES ES16812864T patent/ES2952674T3/en active Active
- 2016-12-08 AU AU2016376027A patent/AU2016376027B2/en active Active
- 2016-12-08 UA UAA201803888A patent/UA122699C2/en unknown
- 2016-12-08 RU RU2018126872A patent/RU2762084C2/en active
- 2016-12-08 BR BR112018010685A patent/BR112018010685A8/en active IP Right Grant
-
2018
- 2018-05-30 ZA ZA2018/03584A patent/ZA201803584B/en unknown
- 2018-05-31 PH PH12018501142A patent/PH12018501142A1/en unknown
- 2018-06-11 IL IL259936A patent/IL259936B2/en unknown
-
2020
- 2020-08-17 US US16/994,932 patent/US20200375972A1/en active Pending
-
2023
- 2023-05-30 JP JP2023088626A patent/JP2023113755A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
HUE063028T2 (en) | 2023-12-28 |
RU2762084C2 (en) | 2021-12-15 |
ES2952674T3 (en) | 2023-11-03 |
ZA201803584B (en) | 2019-04-24 |
US20200375972A1 (en) | 2020-12-03 |
CN108289841A (en) | 2018-07-17 |
BR112018010685A2 (en) | 2018-11-13 |
UA122699C2 (en) | 2020-12-28 |
PL3393451T3 (en) | 2023-12-27 |
EP3393451B1 (en) | 2023-07-19 |
MY186270A (en) | 2021-07-01 |
JP2019505479A (en) | 2019-02-28 |
EP3393451A1 (en) | 2018-10-31 |
US10751336B2 (en) | 2020-08-25 |
AU2016376027B2 (en) | 2022-06-30 |
CA3008208A1 (en) | 2017-06-29 |
WO2017109625A1 (en) | 2017-06-29 |
CN117695207A (en) | 2024-03-15 |
BR112018010685A8 (en) | 2019-02-26 |
MX2018007507A (en) | 2018-08-01 |
JP2023113755A (en) | 2023-08-16 |
AU2016376027A1 (en) | 2018-06-21 |
US20180369225A1 (en) | 2018-12-27 |
RU2018126872A (en) | 2020-01-24 |
RU2018126872A3 (en) | 2020-03-20 |
IL259936B (en) | 2022-10-01 |
IL259936B2 (en) | 2023-02-01 |
KR20180098247A (en) | 2018-09-03 |
PH12018501142A1 (en) | 2019-01-21 |
IL259936A (en) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201805072PA (en) | Nicotine powder delivery system | |
SG11201811250TA (en) | Nicotine inhaler system | |
SG11201807567PA (en) | Aerosol-generating article | |
SG11201809040YA (en) | Hybrid aerosol-generating element and method for manufacturing a hybrid aerosol-generating element | |
SG11201808125RA (en) | Methods for solid tumor treatment | |
SG11201805204WA (en) | Nicotine particle capsule | |
SG11201804384UA (en) | Geometric configurations for gastric residence systems | |
SG11201806002SA (en) | Methods for extending the replicative capacity of somatic cells during an ex vivo cultivation process | |
SG11201811603WA (en) | Novel adeno-associated virus capsid proteins | |
SG11201809594WA (en) | Nicotine particles and compositions | |
SG11201807912SA (en) | Vaccine against rsv | |
SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
SG11201804598RA (en) | Flavoured nicotine powder | |
SG11201808539WA (en) | Mouth piece for cooling of oral tissue of a patient during chemotherapy treatment | |
SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG11201907583TA (en) | Methods for treating complement-mediated diseases and disorders | |
SG11201808525UA (en) | Anti-complement factor bb antibodies and uses thereof | |
SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
SG11201811746TA (en) | Nicotine particle delivery consumable | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201906853QA (en) | Anti-rsv monoclonal antibody formulation | |
SG11201807593TA (en) | Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers | |
SG11201807963WA (en) | Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus |